J. Goldman & Co’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
J. Goldman & Co's PRAX Position: Q3 2026 in Review
J. Goldman & Co reduced its Praxis Precision Medicines (PRAX) stake by 7.4% in Q3 2026, selling an estimated $396K and leaving 14,988 shares worth $4.36M. The position accounts for 0.09% of the portfolio, ranked #255.
J. Goldman & Co first reported a position in PRAX in Q1 2023 and has held it in 10 quarters since. The position peaked at $5.42M in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- J. Goldman & Co held 14,988 shares of Praxis Precision Medicines worth $4.36M as of Q3 2026.
- J. Goldman & Co sold 1,198 Praxis Precision Medicines shares in Q3 2026, an estimated $396K.
- Praxis Precision Medicines made up 0.09% of J. Goldman & Co's portfolio in Q3 2026, its #255 holding.
- J. Goldman & Co first reported a position in Praxis Precision Medicines in Q1 2023 and has held it in 10 quarters since.
- J. Goldman & Co's Praxis Precision Medicines position peaked at $5.42M in Q2 2026.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on J. Goldman & Co's 13F filing for Q3 2026, filed 16 Nov 2026.